Drug Quiz 8 Flashcards
(53 cards)
Dopamine HCL (Intropin) Drug Classification
Sympathomymetic
Sympathetic Agonist
Cathecholamine
Dopamine HCL (Intropin) MOA 1/2
A1 AGONIST—> 2nd Messenger release of Calcium in VSMC—> PERIPHERAL VASOCONSTRICTION—> increased SVR
—>increased BP
Dopamine HCL (Intropin) MOA 2/2
B1 AGONIST—> Increased Intracellular Ca2+ in cardiac cells—> POSITIVE inotropy, chronotropy, and dromotropy.
the mechanism for this drug is dose-dependent.
Dopamine HCL (Intropin) Pharmacokinetics
OoA: <5min.
PE: 5-8min.
DoE: <10min.
HL: 2min.
Dopamine HCL (Intropin) Indications/Field use
Cardiogenic shock
Symptomatic Bradycardia
Septic shock following fluid resuscitation
Dopamine HCL (Intropin) Contraindications
UNCORRECTED HYPOVOLEMIA
If profoundly hypotensive, may give IV fluids concurrently
Dopamine HCL (Intropin) side effects/adverse reactions
Tachycardia Dysrhythmias (A-fib, PVC’s) Chest Pain Dyspnea Nervousness Headache N/V Extravasation necrosis
Dopamine HCL Dose Adult (low dose)
Shock/Bradycardia
ADULT: 2-5 ug/kg/min IV,IO infusion
Low dose) increases blood flow to mesentery and renal (GUT
Dopamine HCL Dose Adult (Medium Dose)
Shock/Bradycardia
ADULT: 5-10 ug/kg/min. IV, IO infusion
Stimulates Beta effects
Dopamine HCL Adult Dose (High Dose)
Shock/Bradycardia
ADULT: 10-20 ug/kg/min. IV, IO infusion
Stimulates Alpha effects
Dopamine HCL Dose Pedi
Shock/Bradycardia
PEDI: 2-20 ug/kg/min IV,IO infusion
Dopamine HCL (Intropin) Precautions
Must be kept out of direct sunlight
Dopamine HCL (Intropin) Drug-Drug Interactions
None
Norepinephrine (Levophed)
Drug classification
Sympathomimetic
Sympathetic agonist
Catecholamine
Norepinephrine (Levophed) MOA 1/2
PrimaryA1 Agonist—> 2nd Messenger release of Calcium in VSMC—> PERIPHERAL VASOCONSTRICTION—> increased SVR
—>increased BP
Norepinephrine (Levophed) MOA 2/2
Secondary B1 Agonist—> Increased intracellular Ca2+ in cardiac cells—> positive inotropy, chronotropy, dromotropy.
Norepinephrine (Levophed) Pharmacokinetics
OoA: <1 min.
PE: <2 min.
DoE: 1-2 min.
H-L: 3 min.
Norepinephrine (Levophed) Indications/Field Use
Cardiogenic Shock
Septic shock following fluid resuscitation
Neurogenic Shock
Norepinephrine (Levophed) Contraindications
Hypovolemia
Norepinephrine (Levophed) Side Effects/Adverse Reactions
Reflex Bradycardia Dysrhythmias Dizziness Headache Anxiety Tremulousness N/V
Norepinephrine (Levophed) Adult Dose
1-30 mcg/min IV, IO infusion—titrate to BPsystolic >90 mmHg
Norepinephrine (Levophed) Pediatric Dose
0.1-2 mcg/kg/min IV, IO infusion—titrate to normotensive systolic BP
Norepinephrine (Levophed) Precautions
Can cause tissue necrosis w/extravasation
Caution with coronary artery disease
Leads to increased myocardial oxygen demand
Norepinephrine (Levophed) Drug-Drug interactions
MAOI and TCA may potentiate cardiovascular effects.